RESUMO
Influenza virus research has recently undergone a shift from a virus-centric perspective to one that embraces the full spectrum of virus-host interactions and cellular signaling events that determine disease outcome. This change has been brought about by the increasing use and expanding scope of high-throughput molecular profiling and computational biology, which together fuel discovery in systems biology. In this review, we show how these approaches have revealed an uncontrolled inflammatory response as a contributor to the extreme virulence of the 1918 pandemic and avian H5N1 viruses, and how this response differs from that induced by the 2009 H1N1 viruses responsible for the most recent influenza pandemic. We also discuss how new animal models, such as the Collaborative Cross mouse systems genetics platform, are key to the necessary systematic investigation of the impact of host genetics on infection outcome, how genome-wide RNAi screens have identified hundreds of cellular factors involved in viral replication, and how systems biology approaches are making possible the rational design of new drugs and vaccines against an ever-evolving respiratory virus.
Assuntos
Interações Hospedeiro-Patógeno , Influenza Humana/imunologia , Infecções por Orthomyxoviridae/imunologia , Orthomyxoviridae/imunologia , Biologia de Sistemas/métodos , Animais , Biologia Computacional , Modelos Animais de Doenças , Interação Gene-Ambiente , Ensaios de Triagem em Larga Escala , Humanos , Imunidade/genética , Vacinas contra Influenza/imunologia , Influenza Humana/epidemiologia , Influenza Humana/genética , Camundongos , Orthomyxoviridae/patogenicidade , Infecções por Orthomyxoviridae/genética , Pandemias , VirulênciaRESUMO
Active positive transcription elongation factor b (P-TEFb) is essential for cellular and human immunodeficiency virus type 1 (HIV-1) transcription elongation. CTIP2 represses P-TEFb activity in a complex containing 7SK RNA and HEXIM1. Recently, the inactive 7SK/P-TEFb small nuclear RNP (snRNP) has been detected at the HIV-1 core promoter as well as at the promoters of cellular genes, but a recruiting mechanism still remains unknown to date. Here we show global synergy between CTIP2 and the 7SK-binding chromatin master-regulator HMGA1 in terms of P-TEFb-dependent endogenous and HIV-1 gene expression regulation. While CTIP2 and HMGA1 concordingly repress the expression of cellular 7SK-dependent P-TEFb targets, the simultaneous knock-down of CTIP2 and HMGA1 also results in a boost in Tat-dependent and independent HIV-1 promoter activity. Chromatin immunoprecipitation experiments reveal a significant loss of CTIP2/7SK/P-TEFb snRNP recruitment to cellular gene promoters and the HIV-1 promoter on HMGA1 knock-down. Our findings not only provide insights into a recruiting mechanism for the inactive 7SK/P-TEFb snRNP, but may also contribute to a better understanding of viral latency.
Assuntos
HIV-1/genética , Proteína HMGA1a/metabolismo , Fator B de Elongação Transcricional Positiva/metabolismo , Regiões Promotoras Genéticas , Proteínas Repressoras/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Linhagem Celular , Regulação da Expressão Gênica , HumanosRESUMO
In 2012, a novel betacoronavirus, designated Middle East respiratory syndrome coronavirus or MERS-CoV and associated with severe respiratory disease in humans, emerged in the Arabian Peninsula. To date, 108 human cases have been reported, including cases of human-to-human transmission. The availability of an animal disease model is essential for understanding pathogenesis and developing effective countermeasures. Upon a combination of intratracheal, ocular, oral, and intranasal inoculation with 7 × 10(6) 50% tissue culture infectious dose of the MERS-CoV isolate HCoV-EMC/2012, rhesus macaques developed a transient lower respiratory tract infection. Clinical signs, virus shedding, virus replication in respiratory tissues, gene expression, and cytokine and chemokine profiles peaked early in infection and decreased over time. MERS-CoV caused a multifocal, mild to marked interstitial pneumonia, with virus replication occurring mainly in alveolar pneumocytes. This tropism of MERS-CoV for the lower respiratory tract may explain the severity of the disease observed in humans and the, up to now, limited human-to-human transmission.
Assuntos
Doenças Transmissíveis Emergentes/virologia , Modelos Animais de Doenças , Pulmão/patologia , Macaca mulatta , Síndrome Respiratória Aguda Grave/patologia , Síndrome Respiratória Aguda Grave/virologia , Animais , Pulmão/virologia , Microscopia Eletrônica de Transmissão , Especificidade da Espécie , Vírion/ultraestrutura , Replicação Viral/fisiologia , Eliminação de Partículas Virais/fisiologiaRESUMO
The positive transcription elongation factor b (P-TEFb) is involved in physiological and pathological events including inflammation, cancer, AIDS, and cardiac hypertrophy. The balance between its active and inactive form is tightly controlled to ensure cellular integrity. We report that the transcriptional repressor CTIP2 is a major modulator of P-TEFb activity. CTIP2 copurifies and interacts with an inactive P-TEFb complex containing the 7SK snRNA and HEXIM1. CTIP2 associates directly with HEXIM1 and, via the loop 2 of the 7SK snRNA, with P-TEFb. In this nucleoprotein complex, CTIP2 significantly represses the Cdk9 kinase activity of P-TEFb. Accordingly, we show that CTIP2 inhibits large sets of P-TEFb- and 7SK snRNA-sensitive genes. In hearts of hypertrophic cardiomyopathic mice, CTIP2 controls P-TEFb-sensitive pathways involved in the establishment of this pathology. Overexpression of the ß-myosin heavy chain protein contributes to the pathological cardiac wall thickening. The inactive P-TEFb complex associates with CTIP2 at the MYH7 gene promoter to repress its activity. Taken together, our results strongly suggest that CTIP2 controls P-TEFb function in physiological and pathological conditions.
Assuntos
Cardiomegalia/metabolismo , Fator B de Elongação Transcricional Positiva/metabolismo , Regiões Promotoras Genéticas , Proteínas Repressoras/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Animais , Miosinas Cardíacas/genética , Miosinas Cardíacas/metabolismo , Cardiomegalia/genética , Cardiomegalia/patologia , Quinase 9 Dependente de Ciclina/genética , Quinase 9 Dependente de Ciclina/metabolismo , Células HEK293 , Humanos , Camundongos , Cadeias Pesadas de Miosina/genética , Cadeias Pesadas de Miosina/metabolismo , Fator B de Elongação Transcricional Positiva/genética , Estrutura Secundária de Proteína , RNA Nuclear Pequeno/genética , RNA Nuclear Pequeno/metabolismo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/metabolismo , Proteínas Repressoras/genética , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Proteínas Supressoras de Tumor/genéticaRESUMO
Mucosal sites are continuously exposed to pathogenic microorganisms and are therefore equipped to control respiratory infections. Type 3 innate lymphoid cells (ILC3) are key players in antimicrobial defense in intestinal mucosa, through interleukin 17 and interleukin 22 (IL-22) production. The present study aimed at analyzing the distribution and function of ILC3 in the respiratory tract. We first observed that lung mucosa harbors a discrete population of ILC3 expressing CD127, CD90, CCR6, and the transcriptional factor RORγt. In addition, lung ILC3 were identified as a major source of IL-22 in response to interleukin 23 stimulation. During Streptococcus pneumoniae infection, ILC3 rapidly accumulated in the lung tissue to produce IL-22. In response to S. pneumoniae, dendritic cells and MyD88, an important adaptor of innate immunity, play critical functions in IL-22 production by ILC3. Finally, administration of the Toll-like receptor 5 agonist flagellin during S. pneumoniae challenge exacerbated IL-22 production by ILC3, a process that protects against lethal infection. In conclusion, boosting lung ILC3 might represent an interesting strategy to fight respiratory bacterial infections.
Assuntos
Interleucinas/metabolismo , Pulmão/metabolismo , Linfócitos/classificação , Linfócitos/fisiologia , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/metabolismo , Animais , Feminino , Interleucina-17/genética , Interleucina-17/metabolismo , Interleucinas/genética , Ativação Linfocitária , Camundongos , Camundongos Knockout , Streptococcus pneumoniae , Interleucina 22RESUMO
BACKGROUND: The NUT midline carcinoma (NMC) is a rare but fatal cancer for which systematic testing of therapy options has never been performed. METHODS: On the basis of disease biology, we compared the efficacy of the CDK9 inhibitor flavopiridol (FP) with a panel of anticancer agents in NMC cell lines and mouse xenografts. RESULTS: In vitro anthracyclines, topoisomerase inhibitors, and microtubule poisons were among the most cytotoxic drug classes for NMC cells, while efficacy of the bromodomain inhibitor JQ1 varied considerably between lines carrying different BRD4 (bromodomain-containing protein 4)-NUT (nuclear protein in testis) translocations. Efficacy of FP was comparable to vincristine and doxorubicin, drugs that have been previously used in NMC patients. All three compounds showed significantly better activity than etoposide and vorinostat, agents that have also been used in NMC patients. Statins and antimetabolites demonstrated intermediate single-agent efficacy. In vivo, vincristine significantly inhibited tumour growth in two different NMC xenografts. Flavopiridol in vivo was significantly effective in one of the two NMC xenograft lines, demonstrating the biological heterogeneity of this disease. CONCLUSIONS: These results demonstrate that FP may be of benefit to a subset of patients with NMC, and warrant a continued emphasis on microtubule inhibitors, anthracyclines, and topoisomerase inhibitors as effective drug classes in this disease.
Assuntos
Antineoplásicos/farmacologia , Carcinoma de Células Escamosas/tratamento farmacológico , Flavonoides/farmacologia , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Piperidinas/farmacologia , Animais , Antraciclinas/farmacologia , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/metabolismo , Linhagem Celular Tumoral , Doxorrubicina/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Neoplasias de Cabeça e Pescoço/genética , Neoplasias de Cabeça e Pescoço/metabolismo , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Proteínas Oncogênicas/genética , Proteínas Oncogênicas/metabolismo , Inibidores da Topoisomerase/farmacologia , Moduladores de Tubulina/farmacologia , Vincristina/farmacologia , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
The 1918 pandemic influenza virus was the most devastating infectious agent in human history, causing fatal pneumonia and an estimated 20 to 50 million deaths worldwide. Previous studies indicated a prominent role of the hemagglutinin (HA) gene in efficient replication and high virulence of the 1918 virus in mice. It is, however, still unclear whether the high replication ability or the 1918 influenza virus HA gene is required for 1918 virus to exhibit high virulence in mice. Here, we examined the biological properties of reassortant viruses between the 1918 virus and a contemporary human H1N1 virus (A/Kawasaki/173/2001 [K173]) in a mouse model. In addition to the 1918 influenza virus HA, we demonstrated the role of the viral RNA replication complex in efficient replication of viruses in mouse lungs, whereas only the HA gene is responsible for lethality in mice. Global gene expression profiling of infected mouse lungs revealed that the 1918 influenza virus HA was sufficient to induce transcriptional changes similar to those induced by the 1918 virus, despite difference in lymphocyte gene expression. Increased expression of genes associated with the acute-phase response and the protein ubiquitination pathway were enriched during infections with the 1918 and 1918HA/K173 viruses, whereas reassortant viruses bearing the 1918 viral RNA polymerase complex induced transcriptional changes similar to those seen with the K173 virus. Taken together, these data suggest that HA and the viral RNA polymerase complex are critical determinants of Spanish influenza pathogenesis, but only HA, and not the viral RNA polymerase complex and NP, is responsible for extreme host responses observed in mice infected with the 1918 influenza virus.
Assuntos
RNA Polimerases Dirigidas por DNA/metabolismo , Hemaglutininas/metabolismo , Vírus da Influenza A Subtipo H1N1/metabolismo , Vírus da Influenza A Subtipo H1N1/patogenicidade , Influenza Humana/virologia , Proteínas Virais/metabolismo , Animais , Linhagem Celular , RNA Polimerases Dirigidas por DNA/genética , Feminino , Hemaglutininas/genética , Humanos , Vírus da Influenza A Subtipo H1N1/enzimologia , Vírus da Influenza A Subtipo H1N1/genética , Influenza Humana/genética , Influenza Humana/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Ligação Proteica , Vírus Reordenados/enzimologia , Vírus Reordenados/genética , Vírus Reordenados/metabolismo , Vírus Reordenados/patogenicidade , Transcrição Gênica , Regulação para Cima , Proteínas Virais/genéticaRESUMO
Host-pathogen interactions provide a fascinating example of two or more active genomes directly exerting mutual influence upon each other. These encounters can lead to multiple outcomes from symbiotic homeostasis to mutual annihilation, undergo multiple cycles of latency and lysogeny, and lead to coevolution of the interacting genomes. Such systems pose numerous challenges but also some advantages to modeling, especially in terms of functional, mathematical genome representations. The main challenges for the modeling process start with the conceptual definition of a genome for instance in the case of host-integrated viral genomes. Furthermore, hardly understood influences of the activity of either genome on the other(s) via direct and indirect mechanisms amplify the needs for a coherent description of genome activity. Finally, genetic and local environmental heterogeneities in both the host's cellular and the pathogen populations need to be considered in multiscale modeling efforts. We will review here two prominent examples of host-pathogen interactions at the genome level, discuss the current modeling efforts and their shortcomings, and explore novel ideas of representing active genomes which promise being particularly adapted to dealing with the modeling challenges posed by host-pathogen interactions.
Assuntos
Interações Hospedeiro-Patógeno , Biologia de Sistemas , Animais , Genoma , Humanos , Probabilidade , Síndrome de Imunodeficiência Adquirida dos Símios/imunologiaRESUMO
The transactivating response element (TAR) of human immunodeficiency virus 1 (HIV-1) is essential for promoter transactivation by the viral transactivator of transcription (Tat). The Tat-TAR interaction thereby recruits active positive transcription elongation factor b (P-TEFb) from its inactive, 7SK/HEXIM1-bound form, leading to efficient viral transcription. Here, we show that the 7SK RNA-associating chromatin regulator HMGA1 can specifically bind to the HIV-1 TAR element and that 7SK RNA can thereby compete with TAR. The HMGA1-binding interface of TAR is located within the binding site for Tat and other cellular activators, and we further provide evidence for competition between HMGA1 and Tat for TAR-binding. HMGA1 negatively influences the expression of a HIV-1 promoter-driven reporter in a TAR-dependent manner, both in the presence and in the absence of Tat. The overexpression of the HMGA1-binding substructure of 7SK RNA results in a TAR-dependent gain of HIV-1 promoter activity similar to the effect of the shRNA-mediated knockdown of HMGA1. Our results support a model in which the HMGA1/TAR interaction prevents the binding of transcription-activating cellular co-factors and Tat, subsequently leading to reduced HIV-1 transcription.
Assuntos
Repetição Terminal Longa de HIV , HIV-1/genética , Proteína HMGA1a/metabolismo , Fator B de Elongação Transcricional Positiva/metabolismo , Produtos do Gene tat do Vírus da Imunodeficiência Humana/metabolismo , Sítios de Ligação , Regulação Viral da Expressão Gênica , Técnicas de Silenciamento de Genes , Células HEK293 , Infecções por HIV/metabolismo , Infecções por HIV/virologia , HIV-1/metabolismo , Proteína HMGA1a/genética , Células HeLa , Humanos , Modelos Genéticos , Conformação de Ácido Nucleico , Regiões Promotoras Genéticas , RNA Viral/genética , RNA Viral/metabolismo , Transcrição Gênica , Produtos do Gene tat do Vírus da Imunodeficiência Humana/genéticaRESUMO
OBJECTIVE: In order to improve fertility in female domestic animals, especially in bitches, several authors recommend the feeding of the amino acid L-Tyrosine during the follicular phase of the oestrous cycle. The aim of this article was a systematic and statistical analysis of current literature in terms of evidence-based medicine. MATERIALS AND METHODS: Literature research, statistical analysis and classification in levels of evidence. RESULTS: Fifteen German and two English studies on the effect of L-Tyrosine on the fertility in domestic animals were found. The statistical analysis and evaluation of evidence showed that most studies feature methodical deficits and often findings were inconsistent with one another. CONCLUSION AND CLINICAL RELEVANCE: Heterogeneous results indicate a considerable need for further research on the effectiveness and dose of L-Tyrosine to legitimate its appliance in practice.
Assuntos
Animais Domésticos/fisiologia , Fertilidade/efeitos dos fármacos , Tirosina/farmacologia , Animais , Relação Dose-Resposta a Droga , Prática Clínica Baseada em Evidências , Feminino , Fase Folicular/efeitos dos fármacos , Tirosina/administração & dosagemRESUMO
BACKGROUND: Leptospirosis in dogs is a multiorgan disease affecting mostly kidneys and liver. OBJECTIVES: The objective was to characterize prevalence, clinical, and radiological features and outcome of dogs with leptospirosis and pulmonary abnormalities. ANIMALS: Fifty dogs with leptospirosis. METHODS: Medical records of dogs diagnosed with leptospirosis at the Small Animal Clinic, Berlin, were reviewed. Diagnosis was based on microscopic agglutination test, blood or urine polymerase chain reaction, and histopathology. Based on clinical and/or radiological signs, patients were grouped into dogs with lung abnormalities (group 1) or without (group 2). Severity of respiratory distress was scored as mild to moderate (grade 1) or severe (grade 2). Thoracic radiographs were scored based on pulmonary changes and location as grade 1 (caudal interstitial pattern), 2 (generalized mild to moderate reticulonodular interstitial pattern), or 3 (generalized severe reticulonodular interstitial pattern with patchy alveolar consolidations). Results of CBC and biochemistry were compared between groups. RESULTS: Thirty-five dogs had radiological pulmonary changes (grade 1: 5; grade 2: 14; grade 3: 16); 31 of them had pulmonary distress (grade 1: 13, grade 2: 18). Sixty-seven percent of the dogs with dyspnea grade 2 were mainly euthanized because of respiratory distress. Fifteen percent of the dogs with dyspnea grade 1 and 21% without clinical respiratory signs were euthanized because of acute renal failure or sepsis. CONCLUSIONS AND CLINICAL IMPORTANCE: In 70% of dogs with leptospirosis pulmonary changes were detected. Lung involvement represented a severe complication causing increased case fatality depending on the severity of respiratory distress.
Assuntos
Doenças do Cão/etiologia , Leptospirose/veterinária , Pneumopatias/veterinária , Testes de Aglutinação/veterinária , Animais , Cães , Leptospirose/complicações , Pneumopatias/complicaçõesRESUMO
The objective of this study was to evaluate the relationships of different insulin-like growth factor-1 (IGF1) measures [5 distinct IGF1 concentrations on particular days, area under the curve (AUC), and linear regression coefficient] in the postpartum period in lactating dairy cows and reproductive performance. A total of 417 healthy multiparous Holstein-Friesian cows were enrolled in the study. Serum samples for the determination of the concentration of IGF1 were collected on d 0, 4, 10, 20, and 40 postpartum (pp). The concentration of total IGF1 in serum was determined by immunometric chemiluminescence immunoassay. All cows were examined for vaginal discharge as a sign of clinical endometritis at 20 d pp by external inspection and rectal palpation. The mean concentration of IGF1 ranged from 57 +/- 18.9 ng/mL within the first 12 h pp to 74 +/- 19.9 ng/mL at 40 d pp. On d 10 pp, first and all artificial insemination conception rates were greater in cows with IGF1 concentrations above the median compared with cows with IGF1 concentrations below the median. Cows with greater AUC (second to fourth quartile) conceived earlier (11.4, 16.0, and 18.8 d) than cows in the first IGF1 quartile (117.0 +/- 43.6). Proportion of cows pregnant within 200 d pp increased significantly from the first to the third IGF1 quartile of AUC (58.7, 66.7, and 74.0%). The proportion of cows culled decreased from the first to the fourth IGF1 quartile. Correlations between IGF1 measures and days to pregnancy were significant (except for the linear regression coefficients) but low (R(2) = 0.0009 to 0.025). Differences between single or composite measurements of IGF1 were not significant. We could also demonstrate a statistically significant correlation between the concentration of IGF1 in serum and the average 10-d milk production (31.6 to 44.0 kg). In conclusion, our study indicates that single or multiple measurements of IGF1 concentration in the postpartum period have very limited value to predict individual fertility in dairy cows.
Assuntos
Bovinos/fisiologia , Lactação/fisiologia , Leite/metabolismo , Reprodução/fisiologia , Somatomedinas/metabolismo , Animais , Bovinos/metabolismo , Feminino , Fertilização/fisiologia , Lactação/sangue , Nevo Sebáceo de Jadassohn , Valor Preditivo dos Testes , GravidezRESUMO
Beagle dogs continue to be used in experimental studies and preclinical and clinical trials, many of which address the usage of anaesthesia. In order to reduce the number of animals, researchers tend to conduct several experiments on a single animal. The question arises, however, as to whether or not this frequent usage involves more than simply additional stress and discomfort for the individual animal. Within the framework of an existing study involving six female Beagle dogs, we investigated the effects of repeated (5) isoflurane anaesthesia with xylazine/levomethadone/fenpipramide premedication carried out at short intervals (2 weeks) and compared these with the effects of two treatments intermitted by a longer resting period (8 weeks). To verify our hypothesis that frequent anaesthesia affects the dog's wellbeing more than the occasional anaesthesia, the following parameters were measured at regular intervals: body weight, body temperature, respiratory rate, blood pressure, reflexes and heart rate, both at rest and during a treadmill exercise. In addition, recovery behaviour subsequent to anaesthesia was monitored for one hour. Our observations indicate that the anaesthetic effects are most prominent 24 h after the anaesthetic treatment. However, crossover analysis of our data cannot show that there is no statistical difference of whether dogs were anaesthetized occasionally or frequently. In our study, it appears that frequent anaesthesia within a two-week period did not affect the wellbeing and general health of Beagle dogs in a super-additive manner and that a minimum of two-week testing-free period is sufficient to ensure complete recovery from the unwanted effects induced by anaesthesia.
Assuntos
Anestesia/veterinária , Anestésicos Inalatórios/administração & dosagem , Bem-Estar do Animal , Cães/fisiologia , Isoflurano/administração & dosagem , Medicação Pré-Anestésica/veterinária , Anestesia/métodos , Período de Recuperação da Anestesia , Animais , Animais de Laboratório , Pressão Sanguínea/efeitos dos fármacos , Temperatura Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Estudos Cross-Over , Ácidos Difenilacéticos/administração & dosagem , Feminino , Frequência Cardíaca/efeitos dos fármacos , Metadona/administração & dosagem , Respiração/efeitos dos fármacos , Xilazina/administração & dosagemRESUMO
Polyvalent clostridial vaccines, composed of a complex mixture of toxoids from up to 9 different species, are highly effective in controlling clostridial diseases in cattle and sheep. Commercially available vaccines usually state that in normal field conditions two doses administered 4 to 6 weeks apart elicit protective antibody levels that will last for one year. However, studies on the development and duration of the antibody response against the different Clostridium species in target animals are scarce and only partial. Evaluating the temporal evolution of the antibody responses upon vaccination in target species is relevant to understand the bases of protective immunity induced by these vaccines and to develop new optimized vaccines. Here, we assessed the antibody response in sheep against each Clostridium component of two different 9-valent Clostridial vaccines over the period of one year. One vaccine was a commercially available vaccine and the other was an experimental vaccine prepared by us with the same antigens that we used to set up a specific ELISA for each Clostridium species. Both vaccines showed similar results, irrespectively of the origin of the antigens used for the ELISAs, with antibody titers that peaked at day 36 after vaccination and large inter individual variations in the magnitude of the response. Antibody titers were maintained up to 90 days and then markedly decreased, becoming even undetectable in some animals 6 months after vaccination. Given that the current scheme of yearly revaccination has largely shown to be effective at controlling the burden of disease, our results strongly suggest that circulating antibody levels cannot completely explain the protective immunity elicited by these vaccines, and prompt for further studies into the correlates of protection of clostridial vaccines.
Assuntos
Vacinas Bacterianas/imunologia , Infecções por Clostridium/veterinária , Doenças dos Ovinos/imunologia , Ovinos/imunologia , Tétano/veterinária , Animais , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias/imunologia , Clostridium , Infecções por Clostridium/imunologia , Infecções por Clostridium/prevenção & controle , Clostridium tetani , Injeções Subcutâneas , Análise de Componente Principal , Doenças dos Ovinos/microbiologia , Doenças dos Ovinos/prevenção & controle , Tétano/imunologia , Tétano/prevenção & controle , Fatores de Tempo , Vacinação/veterináriaRESUMO
For years, GluN3A was solely considered to be a dominant-negative modulator of NMDARs, since its incorporation into receptors alters hallmark features of conventional NMDARs composed of GluN1/GluN2 subunits. Only recently, increasing evidence has accumulated that GluN3A plays a more diversified role. It is considered to be critically involved in the maturation of glutamatergic synapses, and it might act as a molecular brake to prevent premature synaptic strengthening. Its expression pattern supports a putative role during neural development, since GluN3A is predominantly expressed in early pre- and postnatal stages. In this study, we used RNA interference to efficiently knock down GluN3A in 46C-derived neural stem cells (NSCs) both at the mRNA and at the protein level. Global gene expression profiling upon GluN3A knockdown revealed significantly altered expression of a multitude of neural genes, including genes encoding small GTPases, retinal proteins, and cytoskeletal proteins, some of which have been previously shown to interact with GluN3A or other iGluR subunits. Canonical pathway enrichment studies point at important roles of GluN3A affecting key cellular pathways involved in cell growth, proliferation, motility, and survival, such as the mTOR pathway. This study for the first time provides insights into transcriptome changes upon the specific knockdown of an NMDAR subunit in NSCs, which may help to identify additional functions and downstream pathways of GluN3A and GluN3A-containing NMDARs.
Assuntos
Técnicas de Silenciamento de Genes , Células-Tronco Neurais/metabolismo , RNA Mensageiro/genética , RNA Interferente Pequeno/genética , Receptores de N-Metil-D-Aspartato/genética , Animais , Perfilação da Expressão Gênica , Camundongos , Ligação Proteica , Receptores de N-Metil-D-Aspartato/metabolismoRESUMO
TAF6δ is a pro-apoptotic splice variant of the RNA polymerase II general transcription factor, TAF6, that can dictate life vs. death decisions in animal cells. TAF6δ stands out from classical pro-apoptotic proteins because it is encoded by a gene that is essential at the cellular level, and because it functions as a component of the basal transcription machinery. TAF6δ has been shown to modulate the transcriptome landscape, but it is not known if changes in gene expression trigger apoptosis nor which TAF6δ-regulated genes contribute to cell death. Here we used microarrays to interrogate the genome-wide impact of TAF6δ on transcriptome dynamics at temporal resolution. The results revealed changes in pro-apoptotic BH3-only mitochondrial genes that correlate tightly with the onset of cell death. These results prompted us to test and validate a role for the mitochondrial pathway by showing that TAF6δ expression causes cytochrome c release into the cytoplasm. To further dissect the mechanism by which TAF6δ drives apoptosis, we pinpointed BIM and NOXA as candidate effectors. siRNA experiments showed that both BIM and NOXA contribute to TAF6δ-dependent cell death. Our results identify mitochondrial effectors of TAF6δ-driven apoptosis, thereby providing the first of mechanistic framework underlying the atypical TAF6δ apoptotic pathway's capacity to intersect with the classically defined apoptotic machinery to trigger cell death.
Assuntos
Apoptose , Proteína 11 Semelhante a Bcl-2/metabolismo , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Fatores Associados à Proteína de Ligação a TATA/metabolismo , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Cisplatino/farmacologia , Citocromos c/metabolismo , Ontologia Genética , Humanos , Mitocôndrias/efeitos dos fármacos , Ligante Indutor de Apoptose Relacionado a TNF/farmacologia , Fatores de Tempo , Ativação Transcricional/efeitos dos fármacos , Ativação Transcricional/genética , Transcriptoma/genética , Proteína bcl-X/metabolismoRESUMO
To minimize risks from pathogenic prion proteins, particular tissues from bovines and other ruminants have been declared specified risk materials (SRMs), which are required to be removed from the food chain. However, in particular for the sympathetic trunk (ST) as a part of the autonomous nervous system (ANS), which represents a potential transfer route for abnormal prion proteins (PrP(Sc)), this is not the case. Consequently, its destination during cutting procedures deserves attention. In this survey, the handling of the ST in beef cutting plants was recorded during ongoing work. To ease these observations, the ST was separated into five parts, and eight destinations for cuts were identified. By means of an observation sheet, the destination of the respective tissue was recorded. About one-third of the ST went into human consumption, another one-third was disposed of as SRMs, and the last one-third was used for nonfood purposes or disposed of. The rear thoracic and sacral ganglia primarily remained naturally connected to the bones going as SRMs. The stellate, front thoracic, and lumbar ganglia went in a different percent into the food chain. Frequently, workers in the same plant decided differently, even from case to case, on the destination of the tissue, which indicates a lack of standardization.
Assuntos
Encefalopatia Espongiforme Bovina/transmissão , Indústria de Processamento de Alimentos/métodos , Indústria de Processamento de Alimentos/normas , Proteínas PrPSc/isolamento & purificação , Doenças Priônicas/transmissão , Animais , Sistema Nervoso Autônomo/anatomia & histologia , Sistema Nervoso Autônomo/fisiologia , Bovinos , Qualidade de Produtos para o Consumidor , Cadeia Alimentar , Alemanha , ZoonosesRESUMO
The transactivating response element (TAR) structure of the nascent HIV-1 transcript is critically involved in the recruitment of inactive positive transcription elongation factor b (P-TEFb) to the promoter proximal paused RNA polymerase II. The viral transactivator Tat is responsible for subsequent P-TEFb activation in order to start efficient viral transcription elongation. In the absence of the viral transactivator of transcription (Tat), e.g., during latency or in early stages of HIV transcription, TAR mediates an interaction of P-TEFb with its inhibitor hexamethylene bis-acetamide-inducible protein 1 (HEXIM1), keeping P-TEFb in its inactive form. In this study, we address the function of HIV-1 TAR in the absence of Tat by analyzing consequences of HIV-1 TAR overexpression on host cellular gene expression. An RNA chimera consisting of Epstein-Barr virus-expressed RNA 2 (EBER2) and HIV-1 TAR was developed to assure robust overexpression of TAR in HEK293 cells. The overexpression results in differential expression of more than 800 human genes. A significant proportion of these genes is involved in the suppression of cellular immune responses, including a significant set of 7SK-responsive P-TEFb target genes. Our findings identify a novel role for HIV-1 TAR in the absence of Tat, involving the interference with host cellular immune responses by targeting 7SK RNA-mediated gene expression and P-TEFb inactivation.
Assuntos
Regulação da Expressão Gênica , Repetição Terminal Longa de HIV/genética , HIV-1/genética , Imunidade Celular/genética , Fator B de Elongação Transcricional Positiva/metabolismo , RNA Longo não Codificante/metabolismo , Produtos do Gene tat do Vírus da Imunodeficiência Humana/deficiência , Sequência de Bases , Quinase 9 Dependente de Ciclina/metabolismo , Células HEK293 , Proteínas HMGA/metabolismo , Humanos , Modelos Biológicos , RNA Longo não Codificante/química , RNA Longo não Codificante/genética , RNA Viral/genética , RNA Viral/metabolismo , Transdução de Sinais/genética , Produtos do Gene tat do Vírus da Imunodeficiência Humana/metabolismoRESUMO
To address the poor prognosis of mixed lineage leukemia (MLL)-rearranged infant acute lymphoblastic leukemia (iALL), we generated a panel of cell lines from primary patient samples and investigated cytotoxic responses to contemporary and novel Food and Drug Administration-approved chemotherapeutics. To characterize representation of primary disease within cell lines, molecular features were compared using RNA-sequencing and cytogenetics. High-throughput screening revealed variable efficacy of currently used drugs, however identified consistent efficacy of three novel drug classes: proteasome inhibitors, histone deacetylase inhibitors and cyclin-dependent kinase inhibitors. Gene expression of drug targets was highly reproducible comparing iALL cell lines to matched primary specimens. Histone deacetylase inhibitors, including romidepsin (ROM), enhanced the activity of a key component of iALL therapy, cytarabine (ARAC) in vitro and combined administration of ROM and ARAC to xenografted mice further reduced leukemia burden. Molecular studies showed that ROM reduces expression of cytidine deaminase, an enzyme involved in ARAC deactivation, and enhances the DNA damage-response to ARAC. In conclusion, we present a valuable resource for drug discovery, including the first systematic analysis of transcriptome reproducibility in vitro, and have identified ROM as a promising therapeutic for MLL-rearranged iALL.
Assuntos
Depsipeptídeos/farmacologia , Proteína de Leucina Linfoide-Mieloide/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Animais , Antibióticos Antineoplásicos/farmacologia , Linhagem Celular Tumoral/efeitos dos fármacos , Quinases Ciclina-Dependentes/antagonistas & inibidores , Rearranjo Gênico , Xenoenxertos , Inibidores de Histona Desacetilases/farmacologia , Humanos , Recém-Nascido , Camundongos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Inibidores de Proteassoma/farmacologiaRESUMO
We describe a rapid cell-based genetic screen using fission yeast for identifying efficient gene suppression constructs (GSCs) from large libraries (10(5)) for any target sequence for use in human cells. In this system, target sequences are fused to the 5' end of the lacZ reporter gene and expressed in yeast. Random fragment expression libraries derived from the target sequence are screened in the fusion gene-expressing strain using the lacZ gene-encoded colony color phenotype. We demonstrate the utility of this screening assay by identifying a range of different GSCs for the fission yeast ura4 gene and human c-myc and Chk1 sequences, including rare efficient suppressors. GSCs specific for c-myc were shown to regulate expression of both a c-myc-lacZ fusion gene and the endogenous c-myc gene in human cells.